Colistimethate for Injection, USP is indicated for the treatment of acute or chronic infections due to sensitive strains of certain gram-negative bacilli. It is particularly indicated when the infection is caused by sensitive strains of Pseudomonas aeruginosa.
From the U.S. FDA-approved label for Colistimethate sodium. Full label: DailyMed.
Colistimethate for Injection, USP is indicated for the treatment of acute or chronic infections due to sensitive strains of certain gram-negative bacilli. It is particularly indicated when the infection is caused by sensitive strains of Pseudomonas aeruginosa. Colistimethate for Injection, USP has proven clinically effective in treatment of infections due to the following gram-negative organisms: Enterobacter aerogenes, Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeruginosa. Colistimethate for Injection, USP may be used to initiate therapy in serious infections that are suspected to be due to gram-negative organisms and in the treatment of infections due to susceptible gram-negative pathogenic bacilli. To reduce the development of drug-resistant bacteria and maintain the effectiveness of Colistimethate for Injection, USP and other antibacterial drugs, Colistimethate for Injection, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy.
From the U.S. FDA-approved label for Colistimethate sodium. Full label: DailyMed.
Important Colistimethate for Injection, USP is supplied in vials containing colistimethate sodium equivalent to 150 mg colistin base activity per vial. Reconstitution for Intravenous or Intramuscular Administration The 150 mg vial should be reconstituted with 2 mL Sterile Water for Injection, USP. The reconstituted solution provides colistimethate sodium at a concentration equivalent to 75 mg/mL colistin base activity.
Directions from the U.S. FDA-approved label — your doctor or pharmacist may advise differently.
The use of Colistimethate for Injection, USP is contraindicated for patients with a history of sensitivity to the drug or any of its components.
Excerpt from the U.S. FDA-approved label. Talk to a pharmacist or doctor before use.
Maximum daily dose calculated from colistin base activity should not exceed 5 mg/kg/day with normal renal function. Transient neurological disturbances may occur. These include circumoral paresthesia or numbness, tingling or formication of the extremities, generalized pruritus, vertigo, dizziness, and slurring of speech. For these reasons, patients should be warned not to drive vehicles or use hazardous machinery while on therapy. Reduction of dosage may alleviate symptoms. Therapy need not be discontinued, but such patients should be observed with particular care.
Warnings and precautions excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor before use.
The following adverse reactions have been reported: Gastrointestinal - gastrointestinal upset Nervous System - tingling of extremities and tongue, slurred speech, dizziness, vertigo, paresthesia, and seizures Integumentary - generalized itching, urticaria and rash Body as a Whole - fever and anaphylaxis Laboratory Deviations - increased blood urea nitrogen (BUN), elevated creatinine and decreased creatinine clearance…
Excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor about side effects.
164 products from 76 makers in the NepalDoc medicine catalog use this generic:
| Brand | Composition | Maker | Pack |
|---|---|---|---|
| Acostin 1Million IU Injection | Colistimethate Sodium (1Million IU) | Sun Pharmaceutical Industries Ltd | vial of 1 Injection |
| Acostin 3Million IU Injection | Colistimethate Sodium (3Million IU) | Sun Pharmaceutical Industries Ltd | vial of 1 Injection |
| Acostin Forte 2MIU Injection | Colistimethate Sodium (2Million IU) | Sun Pharmaceutical Industries Ltd | vial of 1 Injection |
| Biomyxib Injection | Colistimethate Sodium (500000IU) | Health Biotech Limited | vial of 1 Injection |
| Clarmate 2MIU Injection | Colistimethate Sodium (2Million IU) | Louis and Clark Pharmaceutical | vial of 1 Injection |
| Clistril 1MIU Injection | Colistimethate Sodium (1Million IU) | Novo Medi Sciences Pvt Ltd | vial of 1 Injection |
| Clistril 2MIU Injection | Colistimethate Sodium (2Million IU) | Novo Medi Sciences Pvt Ltd | vial of 1 Injection |
| Clistril 3MIU Injection | Colistimethate Sodium (3Million IU) | Novo Medi Sciences Pvt Ltd | vial of 1 Injection |
| Clomist 2MIU Injection | Colistimethate Sodium (2Million IU) | Mits Healthcare Pvt Ltd | vial of 1 Injection |
| Colbestin 4.5MIU Injection | Colistimethate Sodium (4.5Million IU) | Medic Biologicals And Pharmaceuticals Pvt Ltd | vial of 1 Injection |
| Colicease Injection | Colistimethate Sodium (NA) | Cadila Pharmaceuticals Ltd | vial of 1 Injection |
| Colick 1MIU Injection | Colistimethate Sodium (1Million IU) | Fantabulous Pharma | vial of 1 Injection |
| Colicraft 1Million IU Injection | Colistimethate Sodium (1Million IU) | United Biotech Pvt Ltd | vial of 1 Injection |
| Colifen 1 MIU Injection | Colistimethate Sodium (1Million IU) | Fenclay Lifesciences | vial of 1 Injection |
| Colifen 2 MIU Injection | Colistimethate Sodium (2Million IU) | Fenclay Lifesciences | vial of 1 Injection |
| Colifen 3 MIU Injection | Colistimethate Sodium (3Million IU) | Fenclay Lifesciences | vial of 1 Injection |
| Coligetz 1 MIU Injection | Colistimethate Sodium (1Million IU) | Alniche Life Sciences Pvt Ltd | vial of 1 Injection |
| Coligetz 2MIU Injection | Colistimethate Sodium (2Million IU) | Alniche Life Sciences Pvt Ltd | vial of 1 Injection |
| Coligyl 1MIU Injection | Colistimethate Sodium (1Million IU) | Mankind Pharma Ltd | vial of 1 Injection |
| Coligyl 2MIU Injection | Colistimethate Sodium (2Million IU) | Mankind Pharma Ltd | vial of 1 Injection |
| Coligyl 3MIU Injection | Colistimethate Sodium (3Million IU) | Mankind Pharma Ltd | vial of 1 Injection |
| Coligyl 4.5MIU Injection | Colistimethate Sodium (4.5Million IU) | Mankind Pharma Ltd | vial of 1 Injection |
| Colihar 2 Injection | Colistimethate Sodium (2Million IU) | Baxton Pharmacia | vial of 1 Injection |
| Colijen 1MIU Injection | Colistimethate Sodium (1Million IU) | Swizing Biosciences | vial of 1 Injection |
| Colimeth Injection | Colistimethate Sodium (2Million IU) | Dote Health Care | vial of 1 Injection |
| Colina 1MIU Injection | Colistimethate Sodium (1Million IU) | AAA Pharma Trade Pvt Ltd | vial of 1 Injection |
| Colina 4.5MIU Injection | Colistimethate Sodium (4.5Million IU) | AAA Pharma Trade Pvt Ltd | vial of 1 Injection |
| Colinem 1Million IU Injection | Colistimethate Sodium (1Million IU) | Macleods Pharmaceuticals Pvt Ltd | vial of 1 Injection |
| Colinex 1MIU Powder for Injection | Colistimethate Sodium (1Million IU) | Pollen Healthcure Pvt. Ltd. | vial of 1 Powder for Injection |
| Colinex 3MIU Powder for Injection | Colistimethate Sodium (3Million IU) | Pollen Healthcure Pvt. Ltd. | vial of 1 Powder for Injection |
Showing 30 of 164 catalog products. Search the full catalog in the app.
Brand list from the NepalDoc medicine catalog. Availability varies by pharmacy — call ahead to confirm stock.
Store unreconstituted product between 20º to 25ºC (68º to 77ºF) (see USP Controlled Room Temperature). Store reconstituted solution in refrigerator 2º to 8ºC (36º to 46ºF) or between 20º to 25ºC (68º to 77ºF) and use within 7 days.
Storage information from the U.S. FDA-approved label.
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. A catalog listing does not guarantee that a medicine is in stock at any pharmacy.